Approval clinical trial in Belgium
AQLANE Medical™ received approval to start their multicenter clinical trial entitled “The use of a Polycaprolactone Based Bulking Agent for the Treatment of Female Stress Urinary Incontinence (SUI), a Pivotal Trial”, in Belgium. The University Hospital in Antwerp (UZA) is the first hospital to enroll patients into this 2-year study.
The trial will evaluate the safety and efficacy of the novel bioresorbable urethral bulking agent Urolon™ in female patients with mild to moderate SUI. More information on the company can be found at www.aqlanemedical.com.